Effects of precision health management combined with dual-energy bone densitometer treatment on bone biomarkers in senile osteoporosis patients
Experimental Gerontology · 2024
DOI: 10.1016/j.exger.2024.112642 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Experimental Gerontology, 2024. Verfasst von Zhixing Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China. Hauptthemen laut MEDLINE: Biomarkers, Bone Density, Absorptiometry, Photon, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: This study investigates the effects of precision health management combined with dual-energy X-ray absorptiometry (DXA) therapy on bone biomarkers in elderly osteoporotic patients. METHODS: 236 elderly patients diagnosed with osteoporosis between May 2020 and November 2021 were enrolled from our hospital. Patients were randomly allocated to either the observation group (n = 118), receiving precision health management alongside DXA therapy, or the control group (n = 118), receiving standard treatment. Clinical data were compared between the two groups. Protein levels of bone formation markers (BSAP, OC) and bone resorption markers (CTX, DPD, TRAP) were analyzed using Western blotting. Bone mineral density (BMD) was measured using DXA at baseline, 12 months, and 24 months. Pain levels were assessed using the Visual Analog Scale (VAS) at the same intervals. Osteoporosis knowledge and self-management confidence were evaluated using respective scales before and after intervention. RESULTS: Baseline characteristics did not significantly differ between groups (P > 0.05). The observation group exhibited decreased BSAP and increased OC and OC protein expressions compared to the control group (P 0.05). However, over the course of 12 and 24 months, the observation group exhibited significant increases in BMD (P < 0.05). VAS scores were notably lower in the observation group during both follow-up assessments (P < 0.05). Furthermore, knowledge scores were higher in the observation group at 12 and 24 months (P < 0.05), while self-efficacy scores showed significant improvement in the observation group at both follow-up intervals (P < 0.05). CONCLUSION: Precision health management combined with DXA therapy positively impacts elderly osteoporotic patients by enhancing bone biomarkers, promoting bone growth, and preventing bone loss. This approach leads to increased BMD, reduced fracture risk, improved pain management, and enhanced knowledge and self-management abilities related to osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Management Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China.
- Health Management Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China. Electronic address: pyb-1977@163.com.
- Health Management Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China. Electronic address: clitao1018@163.com.
Zitieren
APA
Du, Z., Yan, X., Liu, Y., Pei, Y., Zhou, J., Zhang, L., Han, D., & Chen, L. (2024). Effects of precision health management combined with dual-energy bone densitometer treatment on bone biomarkers in senile osteoporosis patients. Experimental Gerontology. https://doi.org/10.1016/j.exger.2024.112642
Vancouver
Du Z, Yan X, Liu Y, Pei Y, Zhou J, Zhang L, et al. Effects of precision health management combined with dual-energy bone densitometer treatment on bone biomarkers in senile osteoporosis patients. Experimental Gerontology. 2024. doi:10.1016/j.exger.2024.112642
BibTeX
@article{Du2024,
author = {Du, Zhixing and Yan, Xiaojing and Liu, Yongjian and Pei, Yongbin and Zhou, Jin and Zhang, Lei and Han, Dandan and Chen, Litao},
title = {Effects of precision health management combined with dual-energy bone densitometer treatment on bone biomarkers in senile osteoporosis patients},
journal = {Experimental Gerontology},
year = {2024},
doi = {10.1016/j.exger.2024.112642}
}
EUVIMED